144 related articles for article (PubMed ID: 20887632)
21. [Prostatic biopsy: technic, value and complications].
Gasman D; Abbou CC
Ann Urol (Paris); 1995; 29(5):229-301. PubMed ID: 8638906
[No Abstract] [Full Text] [Related]
22. MR-Guided Transurethral Ultrasound Ablation (TULSA): An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.
Akhlaghpour S
Cardiovasc Intervent Radiol; 2024 Jun; 47(6):702-704. PubMed ID: 38710796
[No Abstract] [Full Text] [Related]
23. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
24. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
[TBL] [Abstract][Full Text] [Related]
25. Transrectal sonography in prostate evaluation.
Boczko J; Messing E; Dogra V
Radiol Clin North Am; 2006 Sep; 44(5):679-87, viii. PubMed ID: 17030220
[TBL] [Abstract][Full Text] [Related]
26. Editorial comment.
Wood BJ; Choyke P; Turkbey B; Pinto P
J Urol; 2013 Jan; 189(1):92. PubMed ID: 23158414
[No Abstract] [Full Text] [Related]
27. Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy.
Ukimura O; Hirahara N; Fujihara A; Yamada T; Iwata T; Kamoi K; Okihara K; Ito H; Nishimura T; Miki T
Int J Urol; 2010 Oct; 17(10):890-3. PubMed ID: 20812938
[TBL] [Abstract][Full Text] [Related]
28. A resource allocation metric for thyroid biopsies.
Hammond I; Schweitzer ME
J Am Coll Radiol; 2011 Jan; 8(1):49-52. PubMed ID: 21211764
[TBL] [Abstract][Full Text] [Related]
29. Editorial comment.
Kuru TH; Hadaschik BA
J Urol; 2013 Dec; 190(6):2025. PubMed ID: 24050904
[No Abstract] [Full Text] [Related]
30. Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy.
Bryk DJ; Llukani E; Huang WC; Lepor H
J Urol; 2015 Nov; 194(5):1234-40. PubMed ID: 26003206
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications.
Yakar D; Hambrock T; Hoeks C; Barentsz JO; Fütterer JJ
Top Magn Reson Imaging; 2008 Dec; 19(6):291-5. PubMed ID: 19512851
[TBL] [Abstract][Full Text] [Related]
32. Editorial comment.
Schilling D; Stenzl A
J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
[No Abstract] [Full Text] [Related]
33. 1.5-T magnetic resonance-guided transgluteal biopsies of the prostate in patients with clinically suspected prostate cancer: technique and feasibility.
Bodelle B; Naguib NN; Schulz B; Eichler K; Müller C; Hansmann ML; Hammerstingl R; Hübner F; Vogl TJ; Zangos S
Invest Radiol; 2013 Jun; 48(6):458-63. PubMed ID: 23385402
[TBL] [Abstract][Full Text] [Related]
34. The Potential Use of Ultrasound-Magnetic Resonance Imaging Fusion Applications in Musculoskeletal Intervention.
Burke CJ; Bencardino J; Adler R
J Ultrasound Med; 2017 Jan; 36(1):217-224. PubMed ID: 27914184
[TBL] [Abstract][Full Text] [Related]
35. Strategies for Biopsy of Musculoskeletal Tumors.
Daley NA; Reed WJ; Peterson JJ
Semin Roentgenol; 2017 Oct; 52(4):282-290. PubMed ID: 28965547
[No Abstract] [Full Text] [Related]
36. Editorial comment.
Cam K
J Urol; 2013 Aug; 190(2):514. PubMed ID: 23680584
[No Abstract] [Full Text] [Related]
37. [Image fusion: use in the control of the distribution of prostatic biopsies].
Mozer P; Baumann M; Chevreau G; Troccaz J
Prog Urol; 2008 Feb; 18(1 Suppl FMC):F15-8. PubMed ID: 18773848
[TBL] [Abstract][Full Text] [Related]
38. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
39. Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer.
Brajtbord JS; Lavery HJ; Nabizada-Pace F; Senaratne P; Samadi DB
BJU Int; 2011 May; 107(9):1419-24. PubMed ID: 20804475
[TBL] [Abstract][Full Text] [Related]
40. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Magn Reson Imaging Clin N Am; 2015 Nov; 23(4):607-19. PubMed ID: 26499278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
